Background: Chronic obstructive pulmonary disease (COPD) is associated with an increased load on the diaphragm. Increased (eccentric) loading has been shown to result in disturbances in the cytoskeleton. Objectives: We hypothesized that due to a continuous overload of the diaphragm in COPD patients, distinct alterations in the membrane-associated cytoskeleton occur, especially in the costameres. Methods: Diaphragm biopsies from 7 COPD patients (forced expiratory volume in 1 s 62 ± 3% predicted) and 5 non-COPD patients (forced expiratory volume in 1 s 105 ± 6% predicted) were obtained. Cryosections of these biopsies were stained with antibodies against the costameric proteins of the focal adhesion complex (vinculin, talin and integrin-β1), the dystroglycan complex (dystrophin and β-dystroglycan) and the spectrin-based membrane cytoskeleton (β-spectrin). Furthermore, in these cryosections, the basal membrane protein laminin was stained. Results: We found no differences in the distribution and staining intensity of the costameric proteins of the focal adhesion complex, the dystroglycan complex and the spectrin-based membrane cytoskeleton in the diaphragm between the COPD and the non-COPD patients. Furthermore, no differences were observed in the expression of laminin in the diaphragm between COPD and non-COPD patients. Conclusions: These results indicate that the increased loading to which the diaphragm is exposed in COPD does not result in disturbances in expression of the costameric system and histological damage of the sarcolemma.

1.
Levine S, Kaiser L, Leferovich J, Tikunov B: Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997;337:1799–1806.
2.
Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N, et al: Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol 2002;92:1205–1213.
3.
Mercadier JJ, Schwartz K, Schiaffino S, Wisnewsky C, Ausoni S, Heimburger M, et al: Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol Lung Cell Mol Physiol 1998;274:L527–L534.
4.
Macgowan NA, Evans KG, Road JD, Reid WD: Diaphragm injury in individuals with airflow obstruction. Am J Respir Crit Care Med 2001;163:1654–1659.
5.
Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas JM, Gea J: Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1734–1739.
6.
Reid WD, MacGowan NA: Respiratory muscle injury in animal models and humans. Mol Cell Biochem 1998;179:63–80.
7.
Machiels HA, Verheul AJ, Croes HJ, Hafmans T, Dekhuijzen PNR: Ultrastructural changes in the diaphragm of aged emphysematous hamsters. Basic Appl Myol 2002;12:203–210.
8.
Komulainen J, Takala TE, Kuipers H, Hesselink MK: The disruption of myofibre structures in rat skeletal muscle after forced lengthening contractions. Pflügers Arch 1998;436:735–741.
9.
Friden J, Lieber RL: Eccentric exercise-induced injuries to contractile and cytoskeletal muscle fibre components. Acta Physiol Scand 2001;171:321–326.
10.
Lieber RL, Shah S, Friden J: Cytoskeletal disruption after eccentric contraction-induced muscle injury. Clin Orthop 2002;(suppl 403):S90–S99.
11.
Boriek AM, Capetanaki Y, Hwang W, Officer T, Badshah M, Rodarte J, et al: Desmin integrates the three-dimensional mechanical properties of muscles. Am J Physiol Cell Physiol 2001;280:C46–C52.
12.
Waterman-Storer CM: The cytoskeleton of skeletal muscle: is it affected by exercise? A brief review. Med Sci Sports Exerc 1991;23:1240–1249.
13.
Huxley AF, Simmons RM: Proposed mechanism of force generation in striated muscle. Nature 1971;233:533–538.
14.
Horowits R, Kempner ES, Bisher ME, Podolsky RJ: A physiological role for titin and nebulin in skeletal muscle. Nature 1986;323:160–164.
15.
Ebashi S, Ebashi F: Alpha-actinin, a new structural protein from striated muscle. 1. Preparation and action on actomyosinatp interaction. J Biochem (Tokyo) 1965;58:7–12.
16.
Clark KA, McElhinny AS, Beckerle MC, Gregorio CC: Striated muscle cytoarchitecture: an intricate web of form and function. Annu Rev Cell Dev Biol 2002;18:637–706.
17.
Yurchenco PD, Cheng YS, Colognato H: Laminin forms an independent network in basement membranes. J Cell Biol 1992;117:1119–1133.
18.
Rezvani M, Ornatsky OI, Connor MK, Eisenberg HA, Hood DA: Dystrophin, vinculin, and aciculin in skeletal muscle subject to chronic use and disuse. Med Sci Sports Exerc 1996;28:79–84.
19.
Frenette J, Cote CH: Modulation of structural protein content of the myotendinous junction following eccentric contractions. Int J Sports Med 2000;21:313–320.
20.
van Lunteren E, Moyer M: Reduced fatigue in diaphragm muscle of merosin-deficient DY/DY dystrophic mice. Respiration 2003;70:636–642.
21.
Ottenheijm CA, Heunks LM, Sieck GC, Zhan WZ, Jansen SM, Degens H, et al: Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:200–205.
22.
McNeil PL, Khakee R: Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 1992;140:1097–1109.
23.
Sam M, Shah S, Friden J, Milner DJ, Capetanaki Y, Lieber RL: Desmin knockout muscles generate lower stress and are less vulnerable to injury compared with wild-type muscles. Am J Physiol Cell Physiol 2000;279:C1116–C1122.
24.
Patel TJ, Lieber RL: Force transmission in skeletal muscle: from actomyosin to external tendons. Exerc Sport Sci Rev 1997;25:321–363.
25.
Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 1993;90:3710–3714.
26.
Fritz VK, Stauber WT: Characterization of muscles injured by forced lengthening. 2. Proteoglycans. Med Sci Sports Exerc 1988;20:354–361.
27.
Lieber RL, Schmitz MC, Mishra DK, Friden J: Contractile and cellular remodeling in rabbit skeletal muscle after cyclic eccentric contractions. J Appl Physiol 1994;77:1926–1934.
28.
Palacio J, Galdiz JB, Alvarez FJ, Orozco-Levi M, Lloreta J, Gea J: Procion orange tracer dye technique vs identification of intrafibrillar fibronectin in the assessment of sarcolemmal damage. Eur J Clin Invest 2002;32:443–447.
29.
Lovering RM, De Deyne PG: Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury. Am J Physiol Cell Physiol 2004;286:C230–C238.
30.
Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y: Interaction of cardiac myocytes and non-myocytes in mechanical stress-induced hypertrophy. Herz 1995;20:109–117.
31.
Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, et al: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991;352:536–539.
32.
Petrof BJ, Stedman HH, Shrager JB, Eby J, Sweeney HL, Kelly AM: Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. Am J Physiol 1993;265:C834–C841.
33.
Newham DJ, Jones DA, Clarkson PM: Repeated high-force eccentric exercise: effects on muscle pain and damage. J Appl Physiol 1987;63:1381–1386.
34.
Kjaer M: Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 2004;84:649–698.
35.
Han XY, Wang W, Myllyla R, Virtanen P, Karpakka J, Takala TE: mRNA levels for alpha-subunit of prolyl 4-hydroxylase and fibrillar collagens in immobilized rat skeletal muscle. J Appl Physiol 1999;87:90–96.
36.
Friden J, Sjostrom M, Ekblom B: A morphological study of delayed muscle soreness. Experientia 1981;37:506–507.
37.
Gosselin LE, Martinez DA, Vailas AC, Sieck GC: Passive length-force properties of senescent diaphragm: relationship with collagen characteristics. J Appl Physiol 1994;76:2680–2685.
38.
Verheul AJ, Croes HJ, Dekhuijzen PNR: Extracellular matrix in diaphragm muscle from COPD patients. Am J Respir Crit Care Med 2005;165:A259.
39.
Kovanen V, Suominen H, Risteli J, Risteli L: Type IV collagen and laminin in slow and fast skeletal muscle in rats – effects of age and life-time endurance training. Coll Relat Res 1988;8:145–153.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.